SynthesisJournal for immunotherapy of cancer2023

Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment.

Yuxuan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.